A 65-year-old man had relapsed follicular lymphoma. When he suffered a fifth relapse, he received a regimen containing bendamustine and rituximab (BR). Four weeks later, he presented with systemic erythema, swelling and bullous lesions of lips, the oral cavity, andnasal mucosa and eye pain. He could not open his mouth and had severe pain. Steven-Johnson syndrome/toxic epidermal necrolysis was diagnosed. With corticosteroid treatment and intravenous administration of oxycodone, he recovered for 2 weeks and was discharged. However, 10 days later, bullous lesions appeared again at lips (Figure 1a) , oral cavity and genital mucosa. In addition, numerous erythematous plaques with Koebner's phenomenon were observed on his trunk (Figure 1b ). Blood test, in which antibody was measured, showed neither candidiasis nor pemphigus. Microscopic examination revealed interface dermatitis with necrotic keratinocytes, which was a histological feature of lichenoid drug eruption. Prednisone 5 mg daily was initiated for his lichenoid drug eruption. Although with 4-month treatment his manifestation recovered little by little, mucosal lesions were intractable. His lymphoma was observed afterward because he achieved partial response by one cycle of BR. One year later, however, his wife became aware of his changing mental status. He eventually died of central nervous system involvement in lymphoma.
